EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preprocedural Systemic Immune-Inflammation Index as a marker of risk for major adverse cardiac events and stroke after transcatheter aortic valve implantation

Finn Syryca, Johannes Krefting, Costanza Pellegrini, Tobias Rheude, N Patrick Mayr, Charlotte Salzmann, Fabian Starnecker, Moritz von Scheidt, Zsuzsanna Wolf, Stefan Holdenrieder, Thorsten Kessler, Hendrik B Sager und 10 weitere

Clinical Research in Cardiology · 02.04.2026

DOI: 10.1007/s00392-026-02909-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 02.04.2026. Verfasst von Finn Syryca und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, School of Medicine and Health, TUM University Hospital German Heart Center, Technical University Munich, Lazarettstraße 36,…. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Systemic Immune-Inflammation Index (SII), calculated as neutrophils × platelets / lymphocytes, reflects the interplay between systemic inflammation and immune status. Its prognostic relevance in patients undergoing transcatheter aortic valve implantation (TAVI) remains poorly understood.

Aim

To evaluate the prognostic significance of preprocedural SII in patients undergoing TAVI.

Methods

This retrospective cohort study included 1822 patients undergoing TAVI for severe aortic stenosis between 2014 and 2023 at two TAVI centers in Germany. Patients were divided into derivation and validation cohorts. Preprocedural SII was calculated from differential blood counts. In the derivation cohort, patients were stratified into tertiles based on preprocedural SII. Using receiver operating characteristics (ROC) analysis an optimized cut-off value for the validation cohort was identified to stratify patients into high- and low-risk groups. A generalized linear model (GLM) was used to identify clinical predictors of SII.

Results

In the derivation cohort, multivariate analysis showed that SII was independently associated with both major adverse cardiovascular events (MACE) (hazard ration [HR]: 1.0001 [1.00001; 1.00002], p = 0.020) and stroke (HR: 1.0003 [1.00002; 1.00004], p < 0.001). In the GLM, SII positively correlated with age ( p = 0.013) and C-reactive protein ( p < 0.001), and inversely with mean aortic gradient ( p = 0.022) and hemoglobin ( p = 0.011). In the external validation cohort, high risk patients (cut-off > 1204) showed an increased risk for one-year all-cause mortality (HR: 2.19 [1.59; 3.02], p < 0.001).

Conclusion

Higher preprocedural SII was independently associated with increase rates of MACE and stroke at one-year following TAVI. A SII cut-off of 1204 effectively stratifies patients into high- and low-risk groups and may provide additional value for preprocedural risk stratification. Graphical Abstract

Schlagwörter

Stichwörter der Autor:innen

Aortic valve stenosisTranscatheter aortic valve implantationsystemic inflammatory index

Autor:innen und Institutionen

  • Department of Cardiology, School of Medicine and Health, TUM University Hospital German Heart Center, Technical University Munich, Lazarettstraße 36, 80636, Munich, Germany.
  • DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
  • Institute of Anaesthesiology, School of Medicine and Health, TUM University Hospital German Heart Center, Technical University Munich, Munich, Germany.
  • Institute of Laboratory Medicine, School of Medicine and Health, TUM University Hospital German Heart Center, Technical University Munich, Munich, Germany.
  • Department of Internal Medicine III Cardiology and Angiology, Saarland University Medical Center, Homburg/Saar, Germany.
  • Department of Cardiac Surgery, School of Medicine and Health, TUM University Hospital German Heart Center, Technical University Munich, Munich, Germany.

Förderung

  • Technische Universität München

Zitieren

APA

Syryca, F., Krefting, J., Pellegrini, C., Rheude, T., Mayr, N. P., Salzmann, C., Starnecker, F., von Scheidt, M., Wolf, Z., Holdenrieder, S., Kessler, T., Sager, H. B., Trenkwalder, T., Cassese, S., Schunkert, H., Kastrati, A., Xhepa, E., Ruge, H., Krane, M., …, & Alvarez-Covarrubias, H. A. (2026). Preprocedural Systemic Immune-Inflammation Index as a marker of risk for major adverse cardiac events and stroke after transcatheter aortic valve implantation. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-026-02909-3

Vancouver

Syryca F, Krefting J, Pellegrini C, Rheude T, Mayr NP, Salzmann C, et al. Preprocedural Systemic Immune-Inflammation Index as a marker of risk for major adverse cardiac events and stroke after transcatheter aortic valve implantation. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-026-02909-3

BibTeX
@article{Syryca2026,
  author = {Syryca, Finn and Krefting, Johannes and Pellegrini, Costanza and Rheude, Tobias and Mayr, N Patrick and Salzmann, Charlotte and Starnecker, Fabian and von Scheidt, Moritz and Wolf, Zsuzsanna and Holdenrieder, Stefan and Kessler, Thorsten and Sager, Hendrik B and Trenkwalder, Teresa and Cassese, Salvatore and Schunkert, Heribert and Kastrati, Adnan and Xhepa, Erion and Ruge, Hendrik and Krane, Markus and Joner, Michael and Graesser, Christian and Alvarez-Covarrubias, Hector A},
  title = {Preprocedural Systemic Immune-Inflammation Index as a marker of risk for major adverse cardiac events and stroke after transcatheter aortic valve implantation},
  journal = {Clinical Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00392-026-02909-3}
}
Kostenlos starten →